Products

Atoxin is now cloning the genes of a few therapeutic proteins, and expect to license out these recombinant gene products within the next few years. Development of PCR-based kits for diagnosis of cancers, bacteria and viruses are also in progress.

PCR-based Diagnostic Kits

Atoxin aims to create PCR-based kits for diagnosis of cancers, bacteria and viruses.

Recombinant Gene Products

Atoxin is cloning the genes of a few therapeutic proteins to create recombinant gene products.